Partially-deleted mitochondrial DNA (DmtDNA) accumulates during aging of postmitotic tissues. This accumulation has been linked to decreased metabolic activity, increased reactive oxygen species formation and the aging process. Taking advantage of cell lines with heteroplasmic mtDNA mutations, we showed that, after severe mtDNA depletion, organelles are quickly and predominantly repopulated with DmtDNA, whereas repopulation with the wild-type counterpart is slower. This behavior was not observed for full-length genomes with pathogenic point mutations. The faster repopulation of smaller molecules was supported by metabolic labeling of mtDNA with [ 3 H]thymidine during relaxed copy number control conditions. We also showed that hybrid cells containing two defective mtDNA haplotypes tend to retain the smaller one as they adjust their normal mtDNA copy number. Taken together, our results indicate that, under relaxed copy number control, DmtDNAs repopulate mitochondria more ef®ciently than full-length genomes.
INTRODUCTION
The human mitochondrial genome is a 16 569 bp circular molecule, containing genes that are necessary for the synthesis of the catalytic components of the oxidative phosphorylation (OXPHOS) system. Although these components are essential for mitochondrial respiration and ATP production, they are intrinsically dependent on factors encoded by the nuclear DNA, synthesized in cytosolic ribosomes and imported into the mitochondria. These include factors that regulate mitochondrial DNA (mtDNA) replication, such as the mtDNA polymerase g. Although several additional protein factors associated with mtDNA replication have been described, it is still unclear how mtDNA replication and copy number are controlled (1, 2) .
Mitochondrial genomes harboring large deletions are known to accumulate both in patients with heteroplasmic mtDNA mutations and in normal individuals during aging, particularly in postmitotic tissues such as muscle and brain (3) . These observations support the mitochondrial theory of aging, which states that the slow accumulation of impaired mitochondria is the driving force of the aging process. This idea is attractive because it can be reconciled with the free radical theory of aging, which argues that oxidative damage plays a key role in senescence. Among the numerous mechanisms known to generate oxidants, leakage of superoxide anion and hydrogen peroxide from the mitochondrial electron transport chain are the chief candidates. Increased damage to mtDNA could exacerbate this leakage of reactive oxygen species (ROS) (4).
It is not known how mtDNA deletions accumulate during aging. Although the smaller size of partially-deleted molecules suggested early on that they could have a replicative advantage (5, 6) , direct evidence of this phenomenon has been lacking. In most cases, partially-deleted mtDNAs (DmtDNAs) contain the same number of replication origins as the wildtype genome but they can be up to 50% shorter (7) . We have previously shown that cells harboring homoplasmic levels of DmtDNA repopulated their organelles with mtDNA faster than cells containing wild-type mitochondrial genomes (8) . In these cells, however, there was no competition between mutated and wild-type genomes, as they were present in a homoplasmic state. Therefore, we could not rule out that differences in mtDNA repopulation were due to different metabolic states of these cells. In the present study, we addressed this issue by studying heteroplasmic cells. Our results showed that mtDNA with large deletions, but not with pathogenic point mutations, repopulates organelles signi®-cantly faster than wild-type genomes in the same cell, particularly during relaxed copy number control.
MATERIALS AND METHODS

Characterization of human cells containing different pathogenic mtDNA mutations
We have used several characterized cell lines containing the osteosarcoma 143B(TK±) nuclear background and various mtDNAs. Cell lines harboring heteroplasmic mtDNA deletions were obtained by fusing 143B/206r°with: (i) an enucleated HeLa/®broblast hybrid line harboring~50% of the 4.9 kb`common deletion' [lines DBH.10.5.n, spanning mtDNA positions 8482±13 459; (9)]; (ii) a patient-derived ®broblast cell line harboring a 7.5 kb partial deletion in the mtDNA was used to generate transmitochondrial cybrids (DHH6.1 and DH2.1, spanning positions 7982±15 504). The cell line D16.10.40 had the same deletion in a homoplasmic state (8, 10) . Two cell lines harboring a heteroplasmic mtDNA point mutation in the tRNA Asn gene (G5703A, lines W91 and W76) and two cell lines harboring a heteroplasmic mtDNA point mutation in the tRNA Leu(UUR) gene (C3256T, lines SUA72 and SUB43) were previously characterized (11, 12) . A cell line harboring a homoplasmic 4 bp apocytochrome b gene deletion was obtained as previously described (13) .
mtDNA depletion and repopulation analysis
The various cell lines were grown in complete medium (DMEM supplemented with 4.5 mg/ml glucose, 50 mg/ml uridine, 10% FCS, 1 mM pyruvate and 10 mg/ml gentamycin) in the presence of 50 ng/ml ethidium bromide (EtBr). EtBr was kept in the media for 15 days, after which cells were fed with complete media without EtBr. Cells were kept between 30 and 80% con¯uence with excess fresh medium to assure exponential growth. At selected days (0, 6, 15, 22, 30 and 45) cells were harvested for DNA extraction.
For each cell line (obtained from all selected treatment days) DNA samples (~5 mg) were digested with PvuII and analyzed by Southern blot using two probes. The ®rst probe corresponded to a non-deleted region (mtDNA position 3305± 4261), whereas the second probe corresponded to the nuclear 18S rDNA gene (14) . All probes were prepared by the random primer method. Hybridizing fragments were quantitated in a Cyclone Phosphoimager (Packard Instruments). Signals were used to determine the ratios between mtDNA/nDNA corresponding to the three concentrations. The intensity of the signal was normalized to day zero in the repopulation analyses.
mtDNA synthesis analysis
Selected hybrid lines were labeled with [ 3 H]thymidine (20 mCi/ml; Perkin Elmer) for the times indicated. Mitochondria were puri®ed by nitrogen cavitation as described (15) and DNA puri®ed by phenol/chlorophorm extraction. Puri®ed mtDNA was digested with PvuII and separated by electrophoresis on a 0.8% agarose gel. The gel was stained with EtBr and the fragments corresponding to mtDNA were visualized under UV light. Approximately 0.2 cm segments were sliced from the agarose lane and dissolved with 200 ml of 7 M NaClO 4 for 30 min at 50°C. The solubilized agarose slice was added to scintillation liquid (10 ml) and c.p.m. measured in a scintillation counter. Cells were either directly labeled in medium containing 10% dialyzed serum or pre-treated with 50 ng/ml of EtBr in complete medium for 3 days, allowed to recover for 24 h and pulse labeled for the times indicated. When necessary, the label was chased for 4 additional days in complete medium. The incorporated c.p.m. were normalized by the number of thymidines in each molecule and a correction factor (1.87) was applied to the DmtDNA counts before the percentage labeled mutated mtDNA was calculated.
mtDNA haplotype analysis
Total DNA from different cell lines was puri®ed as described (14) . For the differentiation between partially-deleted or partially-duplicated mtDNA, Southern blots of PvuII and SnaBI digests were performed as described above, with the exception that the probe outside the deleted region corresponded to positions 140±585. The analyses of point mutations in the tRNA Leu(UUR) and tRNA Asn genes were performed bỳ last cycle hot' PCR as previously described (11, 12) . For the 4 bp deletion in the apocytochrome b gene (D4bp cyt b) analysis,~250 ng of DNA were used to amplify a 93 bp fragment by PCR. We used oligonucleotide primers corresponding to mtDNA position 14 747±14 770 (F) and 14 840± 14 817 (B). The forward primer was end-labeled with [g-32 P]ATP. Labeled products were separated by electrophoresis on a 6% denaturing polyacrylamide gel, dried and exposed to a phosphoimager screen. Radiolabeled fragments were identi®ed and quantitated in a Cyclone (Packard Instruments) phosphoimager storage system (13).
Establishment and genetic characterization of hybrid lines
The cell lines 143B, D16.10.40 and D4cytb3.E were transfected with the respective plasmids pIRES neo , pZEO and pIRES puro , and stable transfectants isolated by selection with the respective drugs. Transfection was performed with lipofectamine as suggested by the manufacturer (Life Technologies). These cells were fused to each other with polyethylene glycol as described (9) . Fusion products were subjected to double selection for the nuclear markers. Individual hybrid clones were isolated by the cloning ring method, expanded and their mtDNA analyzed for (i) the D4cyt b by PAGE of PCR-ampli®ed fragments as described above, (ii) large deletions by Southern blot also as described above.
RESULTS
Observations that mtDNA with large-scale deletions accumulate with age prompted us to study the relative organelle repopulation rate of such molecules. To better understand this process we analyzed several cell lines containing different heteroplasmic mtDNA mutations but having a similar nuclear background, derived from the human osteosarcoma 143B(TK±) cell line. These cell lines were obtained by fusing the mtDNA-less 143B derivative (206r°) to cytoplasts obtained from ®broblasts of patients with mitochondrial disorders. Figure 1 shows the location of the mutations in the mitochondrial genome and their level of heteroplasmy. We investigated for the presence of deletion dimers or partial duplications in the cell lines described above by a series of Southern blots. PvuII and SnaBI digests using probes either inside or outside the deletion region showed that the cell lines used in these experiments contained essentially only the wild-type mtDNA and deletion monomers (not shown).
mtDNA harboring deletions repopulate mitochondria faster than the full-length counterparts in the same cell EtBr has been used extensively to reduce the mtDNA copy number in proliferating cells (16) . We treated osteosarcoma cell lines with 50 ng/ml EtBr for 15 days, after which the drug was removed from the medium and the cells allowed to grow for 30 additional days. Throughout the experiment, the medium was supplemented with pyruvate and uridine to avoid a strong selection against cells defective in respiration, which can be auxotrophic for these substrates (17) . DNA was obtained at different days and analyzed for the ratio mtDNA/ nuclear gene. Figure 2A shows that the EtBr treatment led to a marked depletion of mtDNA followed by a repopulation phase.
Selected cell lines were divided into two groups, one containing heteroplasmic mtDNA large deletions and one containing heteroplasmic mtDNA point mutations. In all cases they were treated with EtBr for 15 days at which point the drug was removed and the cells allowed to grow for 30 additional days. Parallel cultures that were not treated with EtBr were also analyzed to assess¯uctuations in mtDNA heteroplasmy that were independent of EtBr treatment. The EtBr-induced mtDNA depletion was con®rmed for all the treated samples by Southern blot (not shown). The percentages of mutated and wild-type mtDNA were not calculated during days 6 and 15 of EtBr treatment because mtDNA levels were markedly decreased, affecting the reliability of the Southern blot assay.
In the heteroplasmic mtDNA large deletions group, untreated cells showed a small drift towards lower levels of mtDNA mutations (Fig. 2B±D, open triangles) . After 45 days in culture (under non-selective conditions) the percentage of mutated mtDNA decreased by 10±20% depending on the cell line. In the EtBr-treated group, there was an increase in the mutated mtDNA population immediately following the removal of EtBr from the medium (Fig. 2B±D, solid triangles) . Seven days after EtBr removal, the percentage of DmtDNA increased by 6.2 T 4.8% (mean T SD) whereas during the same time in the untreated group the percentage of DmtDNA decreased by 9.1 T 8.8%. Therefore the mean difference in the percent mutated mtDNA between treated and untreated, 7 days after EtBr withdrawal was 15.3% (P = 0.011). The increase in percent of DmtDNA observed in the EtBr treated cells was followed by a drift towards slightly lower levels, con®rming the trend observed in untreated cells (Fig. 2B±D) .
In contrast to the mtDNA large deletions group, increases in the percentage of mutated mtDNA after EtBr treatment/ withdrawal could not be observed in cells heteroplasmic for pathogenic point mutations (Fig. 3) . Overall, there was also a trend for a small reduction in the percentage of point mutated mtDNA with time in culture without treatment. EtBr treatment/withdrawal was not associated with an increase in the percentage of mutated mtDNA. With exception of the cell line SUB43, the other three cell lines showed a decrease in the percentage of mutated mtDNA following the EtBr treatment/ withdrawal (Fig. 3) .
mtDNA harboring large deletions are preferentially replicated under relaxed copy number control
We measured the rate of [ 3 H]thymidine incorporation into cell line DDH2.1, which harbors a heteroplasmic 7.5 kb mtDNA deletion. Cells were pulse-labeled with [ 3 H]thymidine for 20 h both without EtBr and after 3 days EtBr (50 ng/ml) treatment. The EtBr treatment was shorter than in other experiments because a relatively high level of mtDNA was necessary to obtain reliable results with this method. mtDNA puri®ed from labeled cells was digested with PvuII and fractionated by agarose gel electrophoresis. Figure 4A shows that the relative rate of [ 3 H]thymidine incorporation was signi®cantly increased in the partiallydeleted molecule after EtBr treatment. Bars on Figure 4B represent the percentage DmtDNA calculated from the [ 3 H]thymidine-labeled fraction after correction for the number of thymidines (mutated molecule values were multiplied by 1.87). Twenty hours labeling followed by a 4 day chase showed a 3 H-labeled fraction of DmtDNA that was similar to the one obtained by Southern blot data (i.e.~89±92% deleted, horizontal grey bar on Fig. 4B ). The EtBr pre-treatment led to an over-representation of 3 H-labeled fraction of DmtDNA (96% of total, Fig. 4B ).
mtDNA harboring large deletions are preferentially maintained in hybrids with competing mitochondrial genomes
In order to study mtDNA heteroplasmic dynamics in an independent system, we created hybrids containing different types of mitochondrial genomes and assessed if there were speci®c haplotypes that were preferentially maintained. To do so, we used three cell lines that had 143B-derived nuclear background, but each one tagged with a different dominant nuclear marker, namely neomycin-, zeocin-or puromycin-resistance. Figure 5A illustrates the procedure and describes the following cell lines: (i) a neo-resistant cell line with wild-type mtDNA; (ii) a zeo-resistant cell line with a large mtDNA deletion (D7.5 kb mtDNA deletion, D16.10.40); (iii) a puro-resistant cell line with a small 4 bp deletion in the apocytochrome b gene. In contrast to the cell lines used in the previous experiments, these cell lines were homoplasmic for the respective mtDNA haplotypes. Cell fusions were performed and hybrid clones were isolated by double selection according to the nuclear markers present in their nuclei. All media were supplemented with pyruvate and uridine. The expanded clones had their DNA extracted and characterized as described below.
To differentiate mtDNA haplotypes in PN hybrids [i.e. puro (harboring D4 bp) and neo (harboring wt mtDNA)], we ampli®ed a 93 bp fragment¯anking the 4 bp deletion and analyzed the amplicons by PAGE. Surprisingly, PN clones were homoplasmic for the wild-type mtDNA, losing the D4 bp mtDNA (Fig. 5B) . As expected, ampli®cations from ZP clones [i.e. zeo (harboring mtDNA with a D7.5 kb deletion) and puro (harboring D4 bp)] gave rise exclusively to the D4 bp cyt b in Figure 2 . DmtDNA heteroplasmy¯uctuations after induced mtDNA depletion. (A) An osteosarcoma cell line containing high levels of a DmtDNA was treated with 50 ng/ml EtBr for 15 days and allowed to recover for 30 additional days. Cells were harvested at the indicated times and their DNA puri®ed and analyzed for relative levels of mtDNA (mutated or wild-type, closed and open circles, respectively) / nDNA as described in Materials and Methods. (B±D) Three cell lines harboring DmtDNA were subjected to a 15 day EtBr treatment followed by a 30 day recovery period. Parallel cultures growing in the same medium, but without EtBr were also analyzed to assess heteroplasmy¯uctuations related to time in culture. Total DNA extracted at different times was analyzed by Southern blot and the percentage mutated mtDNA represented as ®lled triangles in the EtBr treated series and as open triangles in the control series. The mtDNA levels during EtBr treatment (days 7 and 15) were very low and did not allow a reliable estimation of heteroplasmy. There was a reduction in the percentage mutated mtDNA during normal growth conditions, but EtBr treatment was consistently associated with an increase in percentage mutated mtDNA immediately after the treatment.
this test, as the large deletion present in the zeo-resistant cell line spanned the PCR target (i.e. the D4 bp cyt b region; Fig. 5B ). mtDNA with a large 7.5 kb deletion were distinguished from the wild type and the D4 bp cyt b by Southern analysis. With the exception of one clone (NZ1) NZ clones [i.e. neo (harboring wt mtDNA) and zeo (harboring D7.5 kb mtDNA)] showed a higher percentage of wild type than DmtDNA. In contrast, ZP clones [i.e. zeo (harboring D7.5 kb mtDNA) and puro (harboring D4 bp)] had consistently high levels of the mitochondrial genome harboring a large deletion (Fig. 5C ). Taken together, these results suggest that the hybrid lines tended to preserve the functional mitochondrial genome, probably because of better growth performance. In the cases where both mitochondrial genomes were defective, the smaller one prevailed.
DISCUSSION
mtDNA heteroplasmy under tight copy number control A preferential maintenance of DmtDNA was not observed during normal cell growth conditions (Fig. 2) (18) . In heteroplasmic cells harboring DmtDNA, the fraction of partially-deleted genomes actually showed a small decrease (10±20%) with time under non-selective culture conditions. This reduction was probably observed because cells with relatively higher levels of the wild-type mtDNA have slightly better growth performance, even in rich medium (i.e. media supplemented with high glucose, pyruvate and uridine). Osteosarcoma cybrids with homoplasmic levels of DmtDNA have been shown to grow slightly more slowly than their wildtype counterparts (18) . Hayashi et al. showed that HeLa cybrids with different levels of DmtDNA also had slightly slower population doubling times, with the slowest being the cell line with the highest percentage of mutated mtDNA (19) . Tang et al. (18) found that the DmtDNA fraction decreased by only~10% during prolonged culture, and found it to be not signi®cant. Hayashi et al. found that, after producing cybrids, there was a bias towards an increase in the DmtDNA population after which the levels`stabilized'. However, examination of their data showed a consistent small reduction (5±15%) in the percentage of DmtDNA after 10 weeks post-fusion (19) . Differences in nuclear background may affect the balance between mutated and wild-type mtDNA in non-selective conditions.
mtDNA heteroplasmy under relaxed copy number control
Treatment with EtBr, which reduced the mtDNA copies to very low levels, had a signi®cant effect on the mtDNA repopulation rates within organelles. When EtBr was removed from the media, mtDNA replication ensued at possibly maximum speed, as the still poorly characterized copy number control mechanism attempted to repopulate organelles with the normal copy number or mtDNA mass (20) . Under these conditions of fast replicative activity, DmtDNAs fared signi®-cantly better, repopulating organelles~2±3 times faster than their wild-type counterparts. The present results suggest that increased repopulation rates were not due to an OXPHOS response, as the mutated mtDNA harboring point mutations (but still having an OXPHOS defect) did not show changes in repopulation rates relative to the wild-type mtDNA. Differences in cellular growth were also minimized by the fact that mutated and wild-type genomes were present in the same cell. [ 3 H]Thymidine incorporation was signi®cantly increased in the partially-deleted genomes after mtDNA copy number reduction, corroborating the concept that fast replicative rates favor smaller molecules. These results are compatible with a previous report showing that the rates of [ 3 H]thymidine incorporation were similar between partiallydeleted and wild-type mtDNA when cells were labeled without previous mtDNA depletion (21) . The replicative advantage of smaller mitochondrial genomes may be masked by the slow replication rates in copy number-controlled cells as well as by the cellular selection observed in proliferating cells.
Our observation that replication between the two mtDNA haplotypes was not synchronized suggests that, even though human mitochondrial genomes are associated with proteins and membranes (22) , possibly resembling the yeast nucleoids (23), they do not appear to behave as a group of molecules segregating as a unit as previously suggested (24) . Therefore, in a putative mammalian nucleoid, individual molecules have the potential to replicate independently from others. The nucleoid concept described above (24) was proposed to explain mtDNA heteroplasmy stability. However, our results show that heteroplasmy is not stable during fast mtDNA replication. . Heteroplasmy levels of somatic hybrids generated without selection for OXPHOS function. Three different cell lines were fused to each other as depicted in (A). One contained wild-type mtDNA and a neomycinresistance nuclear marker (N), a second was homoplasmic for a mtDNA 7.5 kb deletion containing a zeocin-resistance nuclear marker (Z) and a third was homoplasmic for a pathogenic 4 bp deletion in cytochrome b gene containing a puromycin-resistance nuclear marker (P). Fusion products were grown in high glucose media containing two of the respective selection drugs (i.e. G418, zeocin or puromycin) and supplemented with uridine. mtDNA heteroplasmy under copy number re-setting
The proliferating hybrid results suggest that when a double dose of mtDNA is introduced in cells, they tend to maintain functional mitochondrial genomes. This conclusion is based on the observation that wild-type genomes were preferentially maintained in hybrids of 143B and either D16.10.40 or D4cyt b. In contrast, in hybrids between D16.10.40 and D4cyt b, the mtDNA with the largest deletion was preferentially maintained. It is unclear why the wild-type mitochondrial genomes were retained at such high relative levels. In particular, the absence of genomes with the cyt b 4 bp deletion in the PN (wt + D4cyt b) clones was surprising. Increased ROS previously associated with this cyt b mutation may make this mtDNA haplotype particularly unfavorable to organelles or cells during the resetting of mtDNA copy number (13) .
Factors in¯uencing mtDNA repopulation rates
It is unlikely that the processivity of the DNA polymerase g differs between mutated and wild-type mtDNA. A`normal' replication rate has been reported for mtDNA with point mutations (25) , and it is likely to be unchanged in partiallydeleted mitochondrial genomes as well. It is more likely that the increased repopulation rate is due to faster completion of the relatively slow mtDNA replication process (26) .
Seidel-Rogol and Shadel recently showed that during the EtBr treatment recovery phase, mtTFA (which is known to be unstable in the absence of mtDNA) and mtRNA polymerase increased to normal levels at a signi®cantly slower rate than mtDNA (27) . Transcripts for these genes have been previously shown to be unaffected by mtDNA depletion (8) . It is likely that such replication factors will be limiting during the repopulation phase and the small amounts of replication factors available after depletion of mtDNA can be re-engaged only after a mtDNA molecule ®nishes its replication cycle. Therefore, replication factors would be available to replicate another molecule sooner when the target molecule is smaller.
Insights into DmtDNA accumulation during aging
The results described in this report provide direct evidence that under conditions of relaxed copy number control, DmtDNAs have an advantage over wild-type molecules in the same cell. This phenomenon, previously suggested based on indirect evidence (28, 29) , has important implications for the mechanisms of mtDNA deletions accumulation during the aging and disease processes.
Although no consensus has been reached, it is generally believed that accumulation of mtDNA deletions is more prevalent than accumulations of mtDNA point mutations during aging of postmitotic tissues (30) . Recent models showed that relaxed replication of mtDNA alone could lead, through random genetic drift, to the clonal expansion of single mutant events during human life (31) . This mechanism could lead to the accumulation or disappearance of a speci®c mtDNA haplotype in some cases, but in our view, genetic drift does not explain the consistent increase of DmtDNA nor excludes the contributing effect of faster repopulation of organelles with smaller genomes during active replication. There is also evidence that mtDNA with partial duplications may accumulate with age (32±34). The mechanism for the accumulation of partial duplications is unclear and cannot be explained by our results. Although mtDNA molecules with partial duplications have additional replication origins that could compensate for the increased length, earlier work showed that mtDNA dimers replicate slower than monomers (35) .
Although there may be important differences between postmitotic tissues and our culture cell system, the observation of heteroplasmy¯uctuations during rapid mtDNA repopulation allows us to draw some conclusions regarding the molecular aspect of differential repopulation rates. Our results are in agreement with previous in situ hybridization experiments that showed that most age-related mtDNA deletions in muscle are caused by clonal expansion of deletions (36, 37) . In muscle, mitochondria with defective function are stimulated to proliferate, and that may increase mtDNA replication, mimicking a relaxed copy number control situation. It also strengthened the view that age-related mtDNA deletions are probably generated at random but their levels gradually increase with time. Our results also raise the possibility that the accumulation of DmtDNAs may be accelerated by metabolic or environmental changes leading to either a transient reduction in mtDNA levels or a relaxation in copy number control.
CONCLUSION
In summary, our results provide evidence that under proliferating conditions, cells harboring relatively high levels of DmtDNAs have a slight reduction in the mutated fraction, probably because of better growth of cells with lower mtDNA mutation loads. This is compatible with the relatively low percentage of mutated mtDNA in proliferating peripheral blood cells and ®broblasts of patients with mitochondrial diseases (38) . On the other hand, at the molecular level, smaller mtDNAs containing the major two replication origins have a repopulating advantage over the wild-type counterpart that operates most ef®ciently during relaxed copy number control. This situation parallels the accumulation of largescale mtDNA deletions in postmitotic tissues, where selection based on cellular growth or survival does not take place, and abnormal organelle proliferation would lead to an increase in mtDNA replication rates (36, 37) .
